Quantity Versus Quality of Anti-Phospholipase A2 Receptor 1 Autoantibodies in the Assessment of Clinical Outcome in Membranous Nephropathy: The Debate Continues

Am J Kidney Dis. 2024 May;83(5):566-568. doi: 10.1053/j.ajkd.2023.12.006. Epub 2024 Jan 22.

Author

Laurence H Beck Jr¹

Affiliation

¹ Nephrology Section, Department of Medicine, Boston Medical Center and Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts. Electronic address: [email protected].

PMID: 38260930
DOI: 10.1053/j.ajkd.2023.12.006

No abstract available

Publication types

Editorial
Letter
Comment

MeSH terms

Autoantibodies* / blood
Autoantibodies* / immunology
Glomerulonephritis, Membranous* / diagnosis
Glomerulonephritis, Membranous* / immunology
Humans
Receptors, Phospholipase A2* / immunology

Substances

Receptors, Phospholipase A2
Autoantibodies
PLA2R1 protein, human